Skip to main content

Table 3 Changes in frequency and % in outcomes 3 and 12 months post-treatment

From: Opiate agonist treatment to improve health of individuals with opioid use disorder in Lebanon

  n (%) p value
Arrested last 3 months—3-month assessment (n = 86)
 Baseline 62 (72.1%)  
 3 months 7 (8.1%) 0.001
Arrested last 3 months—12-month assessment (n = 38)
 Baseline 24 (70.6%)  
 12 months 1 (2.6%) 0.001
Working—3-month assessment (n = 86)
 Baseline 24 (27.9%)  
 3 months 52 (60.5%) 0.02
Working—12-month assessment (n = 38)
 Baseline 12 (31.6%) 0.07
 12 months 30 (78.9%)  
N times overdose—3-month assessment (n = 86)
 Baseline 12 (14.0%)  
 3 months 3 (3.5%)* 0.02
N times overdose—12-month assessment (n = 38)
 Baseline 8 (21.1%)  
 12 months 1 (2.6%) 0.03
Heroin use disorder—3-month assessment (n = 86)
 Baseline 72 (100%)  
 3 months 5 (6.9%) ≤ 0.001
Heroin use disorder—12-month assessment (n = 38)
 Baseline 38 (100%)  
 12 months 1 (2.6%) ≤ 0.001
Cocaine use disorder—3-month assessment (n = 86)
 Baseline 13 (18%)  
 3 months 1 (1.3%) p = 0.04
Cocaine use disorder—12-month assessment (n = 38)
 Baseline 6 (15.8%)  
 12 months 1 (2.6%) p = 0.01
Marijuana use disorder—3-month assessment (n = 86)
 Baseline 18 (25%)  
 3 months 6 (9.7%) p = 0.01
Marijuana use disorder—12-month assessment (n = 38)
 Baseline 8 (21%)  
 12 months 3 (7.8%) 0.04